Shire PLC Expected to Post Q3 2017 Earnings of $3.70 Per Share

Equities research analysts at FBR & Co issued their Q3 2017 EPS estimates for shares of Shire PLC in a research report issued on Wednesday. FBR & Co analyst D. Buck anticipates that the biopharmaceutical company will post earnings of $3.70 per share for the quarter.

from Biotech News